These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 1629370)

  • 81. Clinical grand round: a rapidly progressive pyramidal and extrapyramidal syndrome with a supranuclear gaze palsy.
    Morris HR; Bronstein AM; Shaw CE; Lees AJ; Love S
    Mov Disord; 2005 Jul; 20(7):826-31. PubMed ID: 15747358
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Weight loss in the early stage of progressive supranuclear palsy.
    Tsuge A; Kaneko S; Wate R; Oki M; Nagashima M; Asayama S; Nakamura M; Fujita K; Saito A; Takenouchi N; Kusaka H
    Brain Behav; 2017 Feb; 7(2):e00616. PubMed ID: 28239526
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Progressive supranuclear palsy, a case report.
    Ortiz A; Troya F; de Vera J; Vázquez E
    Arch Soc Esp Oftalmol (Engl Ed); 2024 Jul; 99(7):304-308. PubMed ID: 38768849
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Quantifying apraxia and ophthalmokinetic abnormalities in patients with atypical Parkinsonism: A new way to differential diagnosis?
    Constantinides VC; Paraskevas GP; Potagas C; Stefanis L; Kapaki E
    Parkinsonism Relat Disord; 2019 Apr; 61():39-44. PubMed ID: 30563744
    [No Abstract]   [Full Text] [Related]  

  • 85. Neuro-ophthalmic abnormalities in Tourette's syndrome: functional and anatomic implications.
    Frankel M; Cummings JL
    Neurology; 1984 Mar; 34(3):359-61. PubMed ID: 6583541
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Grandma's eyes.
    Syed H; Harris S; Dubrey S
    Lancet; 2003 Mar; 361(9363):1083. PubMed ID: 12672311
    [No Abstract]   [Full Text] [Related]  

  • 87. [Vertical oculomotor disorders in progressive supranuclear palsy and spino-cerebellar degeneration].
    Nawata Y; Furukawa T; Watanabe M; Kanoh A
    Nihon Jibiinkoka Gakkai Kaiho; 1997 Jul; 100(7):770-81. PubMed ID: 9277099
    [TBL] [Abstract][Full Text] [Related]  

  • 88. In vivo mapping of brain cholinergic function in Parkinson's disease and progressive supranuclear palsy.
    Shinotoh H; Namba H; Yamaguchi M; Fukushi K; Nagatsuka S; Iyo M; Asahina M; Hattori T; Tanada S; Irie T
    Adv Neurol; 2001; 86():249-55. PubMed ID: 11553984
    [No Abstract]   [Full Text] [Related]  

  • 89. "Apraxia" of eyelid opening: an involuntary levator inhibition.
    Lepore FE; Duvoisin RC
    Neurology; 1985 Mar; 35(3):423-7. PubMed ID: 3974904
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cutaneous sympathetic function and cardiovascular function in patients with progressive supranuclear palsy and Parkinson's disease.
    Kikkawa Y; Asahina M; Suzuki A; Hattori T
    Parkinsonism Relat Disord; 2003 Dec; 10(2):101-6. PubMed ID: 14644000
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Visual signs and symptoms of corticobasal degeneration.
    Armstrong RA
    Clin Exp Optom; 2016 Nov; 99(6):498-506. PubMed ID: 27553583
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Pseudo-Parinaud syndrome: eyelid retraction and upgaze palsy associated with oculomotor nucleus syndrome.
    Suda K; Oishi A; Miyamoto K; Yoshimura N
    Clin Exp Ophthalmol; 2009 Sep; 37(7):745-7. PubMed ID: 19788676
    [No Abstract]   [Full Text] [Related]  

  • 93. My dad and progressive supranuclear palsy (PSP).
    Angus-Leppan H
    Pract Neurol; 2020 May; 20(3):263-264. PubMed ID: 32033994
    [No Abstract]   [Full Text] [Related]  

  • 94. The core body temperature rhythm is altered in progressive supranuclear palsy.
    Suzuki K; Miyamoto T; Miyamoto M; Hirata K
    Clin Auton Res; 2009 Feb; 19(1):65-8. PubMed ID: 19224326
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Teaching NeuroImages: FDG-PET in progressive supranuclear palsy.
    Renard D; Collombier L; Castelnovo G; Labauge P
    Neurology; 2010 Apr; 74(14):e60. PubMed ID: 20368626
    [No Abstract]   [Full Text] [Related]  

  • 96. Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson's disease.
    Dubois B; Pillon B; Legault F; Agid Y; Lhermitte F
    Arch Neurol; 1988 Nov; 45(11):1194-9. PubMed ID: 3190499
    [TBL] [Abstract][Full Text] [Related]  

  • 97. How to spot ocular abnormalities in progressive supranuclear palsy? A practical review.
    Phokaewvarangkul O; Bhidayasiri R
    Transl Neurodegener; 2019; 8():20. PubMed ID: 31333840
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Tremor in progressive supranuclear palsy.
    Masucci EF; Kurtzke JF
    Acta Neurol Scand; 1989 Oct; 80(4):296-300. PubMed ID: 2816286
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Progressive supranuclear palsy: report of a case with torticollis, blepharospasm, and dysfluency.
    Janati A
    Am J Med Sci; 1986 Dec; 292(6):391-2. PubMed ID: 3799710
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Progressive spasticity, supranuclear gaze palsy and postural instability, without parkinsonism: what's in a phenotype?
    Ricciardi L; Edwards MJ; Fasano A; Bhatia KP; Stamelou M
    J Neurol Sci; 2018 Jul; 390():84-86. PubMed ID: 29801913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.